Suman VJ - Search Results

1

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).

Freedman RA, Seisler DK, Foster JC, Sloan JA, Lafky JM, Kimmick GG, Hurria A, Cohen HJ, Winer EP, Hudis CA, Partridge AH, Carey LA, Jatoi A, Klepin HD, Citron M, Berry DA, Shulman LN, Buzdar AU, Suman VJ, Muss HB. Freedman RA, et al. Among authors: suman vj. Breast Cancer Res Treat. 2017 Jan;161(2):363-373. doi: 10.1007/s10549-016-4051-1. Epub 2016 Nov 19. Breast Cancer Res Treat. 2017. PMID: 27866278 Free PMC article.

2

Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast cancer.

Ingle JN, Kardinal CG, Suman VJ, Veeder MH, Schaefer PL, Kirschling RJ, Mailliard JA. Ingle JN, et al. Among authors: suman vj. Breast Cancer Res Treat. 1997 May;43(3):193-200. doi: 10.1023/a:1005749115033. Breast Cancer Res Treat. 1997. PMID: 9150898 Clinical Trial.

3

A sandwich type acridinium-linked immunosorbent assay (ALISA) detects soluble ErbB1 (sErbB1) in normal human sera.

Baron AT, Lafky JM, Connolly DC, Peoples J, O'Kane DJ, Suman VJ, Boardman CH, Podratz KC, Maihle NJ. Baron AT, et al. Among authors: suman vj. J Immunol Methods. 1998 Oct 1;219(1-2):23-43. doi: 10.1016/s0022-1759(98)00129-x. J Immunol Methods. 1998. PMID: 9831386

4

Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.

Baron AT, Lafky JM, Boardman CH, Balasubramaniam S, Suman VJ, Podratz KC, Maihle NJ. Baron AT, et al. Among authors: suman vj. Cancer Epidemiol Biomarkers Prev. 1999 Feb;8(2):129-37. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10067810

5

A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma.

Ingle JN, Suman VJ, Kardinal CG, Krook JE, Mailliard JA, Veeder MH, Loprinzi CL, Dalton RJ, Hartmann LC, Conover CA, Pollak MN. Ingle JN, et al. Among authors: suman vj. Cancer. 1999 Mar 15;85(6):1284-92. doi: 10.1002/(sici)1097-0142(19990315)85:6<1284::aid-cncr10>3.0.co;2-p. Cancer. 1999. PMID: 10189133 Clinical Trial.

6

Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis.

Peethambaram PP, Ingle JN, Suman VJ, Hartmann LC, Loprinzi CL. Peethambaram PP, et al. Among authors: suman vj. Breast Cancer Res Treat. 1999 Mar;54(2):117-22. doi: 10.1023/a:1006185805079. Breast Cancer Res Treat. 1999. PMID: 10424402 Clinical Trial.

7

A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women.

Baron AT, Lafky JM, Suman VJ, Hillman DW, Buenafe MC, Boardman CH, Podratz KC, Perez EA, Maihle NJ. Baron AT, et al. Among authors: suman vj. Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1175-85. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11700266

8

A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer.

Perez EA, Geeraerts L, Suman VJ, Adjei AA, Baron AT, Hatfield AK, Maihle N, Michalak JC, Kuross SA, Kugler JW, Lafky JM, Ingle JN. Perez EA, et al. Among authors: suman vj. Ann Oncol. 2002 Aug;13(8):1225-35. doi: 10.1093/annonc/mdf222. Ann Oncol. 2002. PMID: 12181246 Free article. Clinical Trial.

9

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG); Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, Peto R, Bijker N, Solin L, Darby S. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), et al. J Natl Cancer Inst Monogr. 2010;2010(41):162-77. doi: 10.1093/jncimonographs/lgq039. J Natl Cancer Inst Monogr. 2010. PMID: 20956824 Free PMC article. Review.

10

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG); Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), et al. Lancet. 2011 Aug 27;378(9793):771-84. doi: 10.1016/S0140-6736(11)60993-8. Epub 2011 Jul 28. Lancet. 2011. PMID: 21802721 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters